• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis.

作者信息

Olaru Ioana D, Heyckendorf Jan, Andres Sönke, Kalsdorf Barbara, Lange Christoph

机构信息

Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.

Dept of Microbiology, University Hospitals of Leicester, Leicester, UK.

出版信息

Eur Respir J. 2017 May 21;49(5). doi: 10.1183/13993003.00742-2017. Print 2017 May.

DOI:10.1183/13993003.00742-2017
PMID:28529207
Abstract
摘要

相似文献

1
Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis.基于贝达喹啉的耐多药结核病治疗方案。
Eur Respir J. 2017 May 21;49(5). doi: 10.1183/13993003.00742-2017. Print 2017 May.
2
Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India.印度孟买对耐多药结核病患者同情用药使用贝达喹啉的情况。
Eur Respir J. 2017 Mar 22;49(3). doi: 10.1183/13993003.01699-2016. Print 2017 Mar.
3
Daily Dosing for Bedaquiline in Patients with Tuberculosis.贝达喹啉治疗结核病患者的日剂量。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00463-19. Print 2019 Nov.
4
Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique.莫桑比克短程标准化方案治疗耐多药结核病时，注射用药物转为贝达喹啉的患者治疗结局。
Clin Infect Dis. 2019 Oct 30;69(10):1809-1811. doi: 10.1093/cid/ciz196.
5
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.贝达喹啉在儿童和青少年耐多药结核病中的超说明书使用。
Emerg Infect Dis. 2017 Oct;23(10):1711-3. doi: 10.3201/eid2310.170303. Epub 2017 Oct 17.
6
Bedaquiline: finding the pores on the pot.贝达喹啉：寻找壶上的孔隙。
Eur Respir J. 2015 Jul;46(1):288-9. doi: 10.1183/09031936.00022915.
7
Bedaquiline: finding the pores on the pot.贝达喹啉：寻找壶上的小孔。
Eur Respir J. 2015 Jul;46(1):289-91. doi: 10.1183/09031936.00030915.
8
A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment.在使用贝达喹啉治疗后，与耐多药结核病中氯法齐明和贝达喹啉交叉耐药相关的一种突变。
Eur Respir J. 2015 Feb;45(2):554-7. doi: 10.1183/09031936.00142914. Epub 2014 Oct 30.
9
Pharmacokinetics of Bedaquiline in Cerebrospinal Fluid and Serum in Multidrug-Resistant Tuberculous Meningitis.贝达喹啉在耐多药结核性脑膜炎患者脑脊液和血清中的药代动力学
Clin Infect Dis. 2016 Feb 15;62(4):523-4. doi: 10.1093/cid/civ921. Epub 2015 Nov 3.
10
Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia.使用贝达喹啉-地拉马尼治疗耐多药结核病的安全性和有效性：来自法国和拉脱维亚的病例系列
Eur Respir J. 2018 Mar 22;51(3). doi: 10.1183/13993003.02550-2017. Print 2018 Mar.

引用本文的文献

1
Lineage Distribution Using Whole-Genome Sequencing and Bedaquiline, Clofazimine, and Linezolid Phenotypic Profiles among Rifampicin-Resistant Isolates from West Java, Indonesia.利用全基因组测序以及贝达喹啉、氯法齐明和利奈唑胺表型特征对印度尼西亚西爪哇耐利福平分离株进行谱系分布研究。
Int J Microbiol. 2024 Mar 4;2024:2037961. doi: 10.1155/2024/2037961. eCollection 2024.
2
Advances of new drugs bedaquiline and delamanid in the treatment of multi-drug resistant tuberculosis in children.新药贝达喹啉和德拉马尼在儿童耐多药结核病治疗中的进展。
Front Cell Infect Microbiol. 2023 Jun 13;13:1183597. doi: 10.3389/fcimb.2023.1183597. eCollection 2023.
3
A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics.
一个关联了 12289 株结核分枝杆菌分离株基因组与 13 种抗生素定量耐药表型的数据集。
PLoS Biol. 2022 Aug 9;20(8):e3001721. doi: 10.1371/journal.pbio.3001721. eCollection 2022 Aug.
4
Thompson loop: opportunities for antitubercular drug design by targeting the weak spot in demethylmenaquinone methyltransferase protein.汤普森环：通过靶向去甲基甲萘醌甲基转移酶蛋白的薄弱环节进行抗结核药物设计的机遇。
RSC Adv. 2020 Jun 19;10(39):23466-23483. doi: 10.1039/d0ra03206a. eCollection 2020 Jun 16.
5
The efficacy of bedaquiline versus kanamycin in multi-drug resistant tuberculosis: A systematic scoping review.贝达喹啉与卡那霉素治疗耐多药结核病的疗效：一项系统综述。
Health SA. 2021 Nov 29;26:1708. doi: 10.4102/hsag.v26i0.1708. eCollection 2021.
6
Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China.药物暴露和二线药物敏感性与耐多药结核病患者的治疗反应相关：中国多中心前瞻性队列研究。
Eur Respir J. 2022 Mar 24;59(3). doi: 10.1183/13993003.01925-2021. Print 2022 Mar.
7
Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid.儿童耐多药和广泛耐药结核病的治疗：贝达喹啉和德拉马尼的作用
Microorganisms. 2021 May 17;9(5):1074. doi: 10.3390/microorganisms9051074.
8
Safety and Effectiveness of an All-Oral, Bedaquiline-Based, Shorter Treatment Regimen for Rifampicin-Resistant Tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: A Retrospective Cohort Analysis.高人类免疫缺陷病毒（HIV）负担的南非农村地区，使用贝达喹啉为基础的全口服较短疗程方案治疗耐利福平结核病的安全性和有效性：一项回顾性队列分析。
Clin Infect Dis. 2021 Nov 2;73(9):e3563-e3571. doi: 10.1093/cid/ciaa1894.
9
Studies of Persister Cells.持久性细胞研究。
Microbiol Mol Biol Rev. 2020 Nov 11;84(4). doi: 10.1128/MMBR.00070-20. Print 2020 Nov 18.
10
Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study.贝达喹啉表型药敏试验方法及断点的验证：一项多实验室、多国研究。
J Clin Microbiol. 2020 Mar 25;58(4). doi: 10.1128/JCM.01677-19.